360 related articles for article (PubMed ID: 25899161)
21. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
Tur MK; Huhn M; Thepen T; Stöcker M; Krohn R; Vogel S; Jost E; Osieka R; van de Winkel JG; Fischer R; Finnern R; Barth S
Cancer Res; 2003 Dec; 63(23):8414-9. PubMed ID: 14679004
[TBL] [Abstract][Full Text] [Related]
22. A new recombinant immunotoxin hscFv-ETA' demonstrates specific cytotoxicity against chronic myeloid leukemia cells in vitro.
Zhu X; Tao K; Li Y; Li S; Zhang L; Wang D; Zhong L; Feng W
Immunol Lett; 2013; 154(1-2):18-24. PubMed ID: 23954809
[TBL] [Abstract][Full Text] [Related]
23. Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells.
Hashimi SM; Yu S; Alqurashi N; Ipe DS; Wei MQ
Int J Oncol; 2013 Jun; 42(6):1911-8. PubMed ID: 23563899
[TBL] [Abstract][Full Text] [Related]
24. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
[TBL] [Abstract][Full Text] [Related]
25. Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.
Schmidt M; Wels W
Br J Cancer; 1996 Sep; 74(6):853-62. PubMed ID: 8826849
[TBL] [Abstract][Full Text] [Related]
26. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265
[TBL] [Abstract][Full Text] [Related]
27. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells.
Lee S; Park S; Nguyen MT; Lee E; Kim J; Baek S; Kim CJ; Jang YJ; Choe H
BMB Rep; 2019 Aug; 52(8):496-501. PubMed ID: 30670149
[TBL] [Abstract][Full Text] [Related]
28. An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines.
Tur MK; Sasse S; Stöcker M; Djabelkhir K; Huhn M; Matthey B; Gottstein C; Pfitzner T; Engert A; Barth S
Int J Mol Med; 2001 Nov; 8(5):579-84. PubMed ID: 11605031
[TBL] [Abstract][Full Text] [Related]
29. CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
Barth S; Matthey B; Huhn M; Diehl V; Engert A
Cytokines Cell Mol Ther; 1999 Jun; 5(2):69-78. PubMed ID: 10515679
[TBL] [Abstract][Full Text] [Related]
30. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
31. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Bruell D; Stöcker M; Huhn M; Redding N; Küpper M; Schumacher P; Paetz A; Bruns CJ; Haisma HJ; Fischer R; Finnern R; Barth S
Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.
Wang L; Liu B; Schmidt M; Lu Y; Wels W; Fan Z
Prostate; 2001 Apr; 47(1):21-8. PubMed ID: 11304726
[TBL] [Abstract][Full Text] [Related]
33. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors.
Schmidt M; Maurer-Gebhard M; Groner B; Köhler G; Brochmann-Santos G; Wels W
Oncogene; 1999 Mar; 18(9):1711-21. PubMed ID: 10208432
[TBL] [Abstract][Full Text] [Related]
34. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK
Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140
[TBL] [Abstract][Full Text] [Related]
35. Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2.
Schmidt M; McWatters A; White RA; Groner B; Wels W; Fan Z; Bast RC
Gynecol Oncol; 2001 Feb; 80(2):145-55. PubMed ID: 11161852
[TBL] [Abstract][Full Text] [Related]
36. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.
Simon N; Antignani A; Sarnovsky R; Hewitt SM; FitzGerald D
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075852
[TBL] [Abstract][Full Text] [Related]
37. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
38. A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues.
Brehm H; Niesen J; Mladenov R; Stein C; Pardo A; Fey G; Helfrich W; Fischer R; Gattenlöhner S; Barth S
Cancer Lett; 2014 Oct; 352(2):228-35. PubMed ID: 25016058
[TBL] [Abstract][Full Text] [Related]
39. EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells.
Hashimi SM; Grant B; Alqurashi N; Alowaidi F; Wei MQ
Oncol Rep; 2018 Nov; 40(5):2690-2697. PubMed ID: 30226622
[TBL] [Abstract][Full Text] [Related]
40. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins.
Wels W; Beerli R; Hellmann P; Schmidt M; Marte BM; Kornilova ES; Hekele A; Mendelsohn J; Groner B; Hynes NE
Int J Cancer; 1995 Jan; 60(1):137-44. PubMed ID: 7814146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
